
Acasti Pharma (ACST) Earnings Dates & Reports
Acasti Pharma (ACST) Most Recent Earnings
Report DateAug 9, 2024
Period EndingQ1 2025
Est. EPS-$0.25
Actual EPS-$0.24
EarningsBeat
Acasti Pharma (ACST) Earnings
View the latest Acasti Pharma (ACST) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Acasti Pharma (ACST)
Order type
Buy in
Order amount
Est. shares
0 shares
Acasti Pharma (ACST) Earnings per Share (EPS) History
Signup for full accessBrowse free
Acasti Pharma (ACST) Latest Earnings
The value each ACST share was expected to gain vs. the value each share gained.
Acasti Pharma (ACST) reported its most recent earnings on Aug 9, 2024 for Q1 2025, posting earnings per share (EPS) of -$0.24. This exceeded analysts' expectations of -$0.25 by 4.00%, marking a Beat.
For comparison, Acasti Pharma reported EPS of -$0.54 in the same quarter last year.
The company is expected to announce its next earnings report on 01/21/2025, with analysts projecting an EPS of $0.
Acasti Pharma (ACST) Earnings History
Acasti Pharma (ACST) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Acasti Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 9, 2024 | — | — | — |
Jun 21, 2024 | — | — | — |
Feb 12, 2024 | — | — | — |
Nov 13, 2023 | — | — | — |
Acasti Pharma (ACST) Earnings FAQs
Acasti Pharma (ACST) last reported earnings on Aug 9, 2024 for Q1 2025, posting an EPS of -$0.24, which Beat the estimate of -$0.25 by 4.00%.
For Q1 2025, Acasti Pharma (ACST) reported an EPS of -$0.24, exceeding analysts' estimate of -$0.25 by 4.00%.
For Q1 2025, Acasti Pharma (ACST) Beat expectations with an actual EPS of -$0.24 vs. an estimated EPS of -$0.25.
Following the last earnings report on Aug 9, 2024, Acasti Pharma (ACST)'s stock price moved — from — to —.
The next Acasti Pharma (ACST) earnings call is scheduled for Jan. 21, 2025, where executives will discuss financial results and outlook.